The authors compared the efficacy of a self-applied modified Semont maneuver (MSM) with self-treatment with a modified Epley procedure (MEP) in 70 patients with posterior canal benign paroxysmal positional vertigo. The response rate after 1 week, defined as absence of positional vertigo and torsional/upbeating nystagmus on positional testing, was 95% in the MEP group (n ϭ 37) vs 58% in the MSM group (n ϭ 33; p Ͻ 0.001). Treatment failure was related to incorrect performance of the maneuver in the MSM group, whereas treatment-related side effects did not differ significantly between the groups.
Posterior canal benign paroxysmal positional vertigo (PC-BPPV) is caused by dislodged otoconia that move within the PC whenever head position is changed. The resulting endolymph flow activates hair cell receptors, causing short-lasting vertigo and a mixed torsional/ upbeating nystagmus. This "canalolithiasis" hypothesis has been corroborated by the success of therapistguided positioning maneuvers that aim to clear the PC of trapped particles. In controlled trials, single applications of the Epley procedure 1 or the Semont maneuver 2 relieved 70 to 90% of patients. [3] [4] [5] However, this indicates that some patients require repeated treatment until positional vertigo resolves completely. Therefore, complementary self-treatment is a desirable option to abort BPPV. We recently showed that selftreatment with a modified Epley procedure (MEP) relieved 64% of 28 patients within 1 week, whereas the Semont maneuver has not yet been evaluated for selftreatment. 6 Therefore, we compared the efficacy of selftreatment with a modified Semont maneuver (MSM) and the MEP.
Patients and methods. Forty-one outpatients with unilateral PC-BPPV from a dizziness clinic and 29 patients from a neurologist's practice were included according to the following criteria: Patients who had received any positioning maneuver during the acute episode of BPPV, patients with bilateral or horizontal canal BPPV, and patients who could not reliably perform selftreatment because of language problems or lack of mobility were excluded.
Seventy-nine patients were eligible. After giving informed consent according to the local ethics committee, patients were randomly assigned to apply MEP (n ϭ 42) or MSM (n ϭ 37). Five patients in the MEP group and four in the MSM group were lost to follow-up. Seven of these nine patients did not return for positional testing, and two did not complete the exercise because of concurrent cardiac arrhythmia or a sore hip. Therefore, statistical analysis was performed on 70 patients (10 men, 60 women; age, 35 to 80 years [mean, 60 Ϯ 12 years]). The median duration of acute BPPV was 8 weeks. BPPV was idiopathic in 55 patients or occurred after head trauma (n ϭ 4) or vestibular disease (n ϭ 11). Age, sex, and mean duration of the acute episode did not differ significantly between the two groups.
All patients received an illustrated instruction with their specific exercise for the affected ear (figure 1). The sequence of head and body movements was explained. Patients then performed the maneuver once under supervision of the instructing physician. Patients performed the exercise three times daily until positional vertigo had ceased for at least 24 hours. They indicated in a diary whether positional vertigo occurred during each treatment session to determine the number of sessions needed for subjective relief of vertigo and documented treatment-related side effects (e.g., nausea, gait imbalance, and dizziness). Successful treatment after 1 week was defined as absence of positional vertigo and absence of nystagmus on positional testing. Patients were asked to perform the maneuver again on their second visit to assess accuracy of treatment execution. Results. At follow-up evaluation after 1 week, 35 of 37 patients (95%; CI, 81 to 99%) in the MEP group were asymptomatic and showed a negative positional test, whereas in the MSM group, only 19 of 33 patients (58%; CI, 39 to 75%) were cured (relative risk, 1.64; CI, 1.21 to 2.22). Figure 2 shows the number of treatment sessions patients performed until they felt relieved from positional vertigo. The two groups did not differ significantly with respect to treatment-related side effects. Seven of 37 patients (19%; CI, 8 to 35%) in the MEP group and 12 of 33 patients (36%; CI, 20 to 55%) in the MSM group performed the maneuver incorrectly (p Ͼ 0.05). However, although incorrect performance had no effect on treatment outcome in the MEP group (p Ͼ 0.05), there were significantly more treatment failures in the MSM group among patients who performed the maneuver incorrectly compared with those who made no mistakes (p Ͻ 0.05). The most frequent mistake was a too slow head and body movement in the MSM group (n ϭ 9) and an incorrect head rotation in any of the head positions in the MEP group (n ϭ 7). Age, sex, and duration of the acute episode of BPPV were not associated with treatment outcome. Similarly, a logistic regression including age, sex, positioning maneuver, duration of the acute episode, and accuracy of treatment performance showed that only inaccurate performance and positioning maneuver were significantly associated with outcome.
Discussion. Our study shows that self-treatment with MEP is more effective to abolish PC-BPPV within 1 week compared with self-treatment with MSM. Whereas BPPV resolved in 95% of patients who applied MEP, MSM cured only 58% of patients. The response rate in both groups was higher than would have been expected from spontaneous remissions within 1 to 2 weeks reported in previous studies, ranging from 0 to 50%. 4, 5, 8 The efficacy of MEP is comparable with the Epley procedure and the Semont maneuver, with success rates ranging from 70% after single application to nearly 100% after repeated application. [1] [2] [3] [4] [5] In a comparative study, the Epley procedure and the Semont maneuver were found to be equally effective with response rates of 90 to 95% after one or two applications. 9 In view of these results, we considered an untreated control group unjustified from an ethical point of view. The rapid resolution of positional vertigo within a few days in most of our patients after a median duration of 8 weeks argues for a treatment effect and against a spontaneous remission.
In a previous, nonrandomized study, we reported a lower success rate of 64% for self-treatment with MEP (n ϭ 28), which was, however, superior to treatment with Brandt-Daroff exercises 10 (23% response rate after 1 week; n ϭ 26). 6 The Semont maneuver as selftreatment was evaluated for the first time in this study. Although less effective than MEP, MSM successfully relieved half of patients from BPPV. Failure of MSM was related to incorrect maneuver execution. The most frequent mistake was a too slow head and body movement. During the Semont maneuver, the particles sink to the lowermost point when the patient lies down on the affected side. When the patient then moves in one swift movement toward the contralateral side, the particles, because of inertia, do not immediately fall back toward the ampullary end of the PC but may pass its vertex and fall out through its upper open end. If the movement is not performed sufficiently swiftly, the particles, instead of passing the vertex, fall back toward the cupula. Conversely, incorrect performance of MEP did not adversely affect treatment outcome, indicating that the step-wise propagation of particles through the PC induced by the MEP is more robust with respect to minor deviations from treatment instructions. Our results confirm that self-treatment may provide rapid relief from PC-BPPV and should be considered as complementary treatment especially for patients who fail to respond to single therapist-guided positioning maneuvers. It may also be a viable tool for patients with frequent recurrences rendering them independent from costly and time-consuming medical care. Because, according to our data, MEP is more effective than MSM in relieving BPPV, we recommend MEP as first-line self-treatment approach. 
